Literature DB >> 14810268

Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

D A KARNOFSKY, J H BURCHENAL, G C ARMISTEAD, C M SOUTHAM, J L BERNSTEIN, L F CRAVER, C P RHOADS.   

Abstract

Entities:  

Keywords:  MELAMINE; NEOMYCIN

Mesh:

Substances:

Year:  1951        PMID: 14810268     DOI: 10.1001/archinte.1951.03810040002001

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  43 in total

1.  TRYPSIN in thrombo-embolic disease.

Authors: 
Journal:  Br Med J       Date:  1955-06-04

2.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

3.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

4.  Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.

Authors:  L R WASSERMAN
Journal:  Bull N Y Acad Med       Date:  1954-05

5.  The treatment of leukemia.

Authors:  J H BURCHENAL
Journal:  Bull N Y Acad Med       Date:  1954-06

6.  Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.

Authors:  E PATERSON; P B KUNKLER; A L WALPOLE
Journal:  Br Med J       Date:  1953-01-10

7.  [Chemotherapy of malignancies with 2, 4, 6-triethylenimino-s-triazin].

Authors:  G POLEMANN
Journal:  Arch Dermatol Syph       Date:  1952-07

8.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

9.  Current trends in cancer chemotherapy.

Authors:  B E HALL; F M WILLETT; T V FEICHTMEIR; E B REED; W F DOWLING
Journal:  Calif Med       Date:  1956-01

Review 10.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.